| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Evotec-Aktie: Das könnte für einen weiteren Kursanstieg sprechen | 1.018 | sharedeals.de | Am Mittwoch war die Erleichterung über die Waffenruhe im Iran-Konflikt deutlich zu spüren. Hohe Kursanstiege waren zu verzeichnen. Das Biotech-Unternehmen Evotec konnte ebenfalls deutlich zulegen. Am... ► Artikel lesen | |
| Do | Mutares: Exklusiv-Interview - Deutz, Elmos, Evotec, Infineon und Rheinmetall - Börse Frankfurt | 978 | 4investors | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | |
| Do | EQS-Adhoc: Heidelberg Pharma AG: Heidelberg Pharma legt Dosis für Phase II-Studie (RP2D) mit dem ADC-Kandidaten HDP-101 fest | 843 | EQS Group (DE) | EQS-Ad-hoc: Heidelberg Pharma AG / Schlagwort(e): Sonstiges
Heidelberg Pharma AG: Heidelberg Pharma legt Dosis für Phase II-Studie (RP2D) mit dem ADC-Kandidaten HDP-101 fest
09.04.2026... ► Artikel lesen | |
| Do | Idorsia Pharmaceuticals Ltd: Idorsia welcomes Amer Joseph as new Chief Medical Officer and Head of Global Clinical Development | 463 | GlobeNewswire (Europe) | Idorsia thanks Alberto Gimona - most recently Head of Global Clinical Development and Medical Affairs - and wishes him all the best for a well-deserved retirementAmer Joseph joins Idorsia as EVP, Chief... ► Artikel lesen | |
| Do | Basilea Pharmaceutica International Ltd, Allschwil: Basilea erhält zusätzliche USD 6 Mio. von CARB-X für die klinische Entwicklung des Antibiotikums BAL2420 | 451 | GlobeNewswire (Deutschland) | Zusage der finanziellen Förderung nach erfolgreichem Abschluss präklinischer Studien und Erhalt der Genehmigung zur Durchführung klinischer Studien Zusätzliche USD 6 Mio. für die erstmalige Erprobung... ► Artikel lesen | |
| Do | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 09.04.2026 | 426 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 09.04.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 09.04.2026ISIN NameCA29286M1059 ENGENE... ► Artikel lesen | |
| Do | Strategische Weichenstellung im Exosomenmarkt | Small- & Micro Cap Investment | |||
| Do | Zymeworks Inc.: Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth | 281 | GlobeNewswire (Europe) | • Adam Schayowitz, Ph.D., MBA appointed as Head of R&D• Scott Platshon appointed as Chief Business Officer VANCOUVER, British Columbia, April 09, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq:... ► Artikel lesen | |
| Do | Kymera Therapeutics, Inc.: Kymera Therapeutics Announces Gilead Sciences' Option Exercise to License KT-200, Oral CDK2 Molecular Glue Degrader Development Candidate | 278 | GlobeNewswire (Europe) | KT-200 is a first-in-class, oral CDK2 molecular glue degrader development candidate Option exercise of KT-200 triggers a $45 million milestone payment to Kymera from Gilead Sciences WATERTOWN, Mass.... ► Artikel lesen | |
| Do | Tempus AI Expands Collaboration With Gilead Sciences To Maximize Insights In Oncology Pipeline | 276 | AFX News | FOSTER CITY (dpa-AFX) - Healthcare technology company Tempus AI, Inc. (TEM) Thursday announced an expanded, multi-year collaboration with Gilead Sciences, Inc. (GILD) to build and advance its... ► Artikel lesen | |
| Do | Vanda Pharmaceuticals Inc.: Vanda Pharmaceuticals Calls on FDA to Withdraw Proposal from FY 2027 Legislative Agenda That Would Extend Drug Review Timelines | 274 | PR Newswire | WASHINGTON, April 9, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today highlighted a legislative proposal contained in the FDA's FY 2027... ► Artikel lesen | |
| Do | Zeo ScientifiX, Inc.: Regen Therapy Partners with Stealth Health to Bring Specialized Telemedicine Services and Longevity Programs to 3,000 Clinics - Powered by an Exclusive Scientific and Biologics Strategic Collaboration with ZEO ScientifiX | 267 | ACCESS Newswire | Regen Therapy's 24,000-practitioner network will unlock a fully integrated care ecosystem - featuring Stealth Health's licensed prescriber team and specialized therapies, Metabolic Code-driven longevity... ► Artikel lesen | |
| Do | Hypha Labs, Inc. Announces Partnership with Mycology Resources, LLC | 260 | ACCESS Newswire | Companies Combine Technology, Cultivation, and Global Distribution LAS VEGAS, NV / ACCESS Newswire / April 9, 2026 / Hypha Labs, Inc. (OTCQB:FUNI), a biotechnology innovator in the functional mushroom... ► Artikel lesen | |
| Do | C4 Therapeutics Enters Collaboration Agreement With Roche | 258 | AFX News | SOUTH SAN FRANCISCO (dpa-AFX) - C4 Therapeutics (CCCC) has entered into a new collaboration agreement with Roche (RHHBY, RO.SW, ROG.SW) to advance research in the degrader-antibody conjugate... ► Artikel lesen | |
| Do | Basilea Pharmaceutica International Ltd, Allschwil: Basilea awarded additional CARB-X funding of USD 6 million to support the clinical development of antibiotic BAL2420 | 253 | GlobeNewswire (Europe) | Funding is awarded following successful completion of IND-enabling studies and clinical study authorization USD 6 million in additional funding to support antibiotic BAL2420 (LptA inhibitor) first-in-human... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | Dividende 12M | Div.-Rendite | Erw. Dividende | Erw. Ex.-Datum | |
|---|---|---|---|---|---|---|
| BB BIOTECH | 48,300 | 2,47 | +5,11 % | 2,25 | 23.03.2026 | |
| CSL | 85,69 | 2,61 | +3,05 % | 1,84 | 10.03.2026 | |
| AMGEN | 303,85 | 8,25 | +2,72 % | 2,52 | 15.05.2026 | |
| RECORDATI | 49,200 | 1,30 | +2,64 % | 0,71 | 18.05.2026 | |
| NOVONESIS | 51,58 | 0,87 | +1,69 % | 4,25 | 20.03.2026 | |
| SINO BIOPHARM | 0,643 | 0,01 | +1,56 % | 0,05 | 24.06.2026 | |
| GENUS | 29,800 | 0,38 | +1,28 % | 0,11 | 05.03.2026 | |
| VITROLIFE | 8,820 | 0,10 | +1,13 % | 1,10 | 06.05.2026 | |
| 3SBIO | 2,760 | 0,03 | +1,09 % | 0,25 | 21.07.2026 | |
| BIOMERIEUX | 89,55 | 0,90 | +1,01 % | 0,98 | 09.06.2026 |